Bank Of New York Mellon Corp Voyager Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.94 - $6.61 $486,530 - $651,005	98,488 New	98,488 $600,000
Q2 2022 Aug 15, 2022	BUY	$4.82 - $10.09 $270,479 - $566,210	56,116 Added 131.72%	98,717 $584,000
Q4 2021 Feb 11, 2022	SELL	$2.47 - $5.55 $113,091 - $254,112	-45,786 Reduced 51.8%	42,601 $115,000
Q3 2021 Nov 12, 2021	SELL	$2.63 - $4.12 $7,545 - $11,820	-2,869 Reduced 3.14%	88,387 $232,000
Q2 2021 Aug 11, 2021	SELL	$3.94 - $5.44 $336,215 - $464,216	-85,334 Reduced 48.32%	91,256 $376,000
Q1 2021 May 13, 2021	SELL	$4.61 - $9.04 $7,546 - $14,798	-1,637 Reduced 0.92%	176,590 $831,000
Q4 2020 Feb 09, 2021	SELL	$7.15 - $12.28 $6.89 Million - $11.8 Million	-963,999 Reduced 84.4%	178,227 $1.27 Million
Q3 2020 Nov 12, 2020	BUY	$10.01 - $13.75 $198,107 - $272,126	19,791 Added 1.76%	1,142,226 $12.2 Million
Q2 2020 Aug 12, 2020	BUY	$8.05 - $14.21 $1.81 Million - $3.19 Million	224,246 Added 24.97%	1,122,435 $14.2 Million
Q1 2020 May 06, 2020	BUY	$6.8 - $14.66 $2.32 Million - $4.99 Million	340,650 Added 61.1%	898,189 $8.22 Million
Q4 2019 Feb 14, 2020	BUY	$12.82 - $16.85 $5.86 Million - $7.71 Million	457,473 Added 457.17%	557,539 $7.78 Million
Q3 2019 Nov 07, 2019	BUY	$16.31 - $28.29 $3,359 - $5,827	206 Added 0.21%	100,066 $1.72 Million
Q2 2019 Aug 12, 2019	BUY	$19.18 - $27.88 $200,661 - $291,680	10,462 Added 11.7%	99,860 $2.72 Million
Q1 2019 May 14, 2019	BUY	$8.0 - $19.66 $7,512 - $18,460	939 Added 1.06%	89,398 $1.71 Million
Q4 2018 Feb 11, 2019	BUY	$8.59 - $18.05 $30,434 - $63,951	3,543 Added 4.17%	88,459 $831,000
Q3 2018 Nov 09, 2018	BUY	$17.11 - $21.74 $20,634 - $26,218	1,206 Added 1.44%	84,916 $0
Q2 2018 Aug 06, 2018	BUY	$16.76 - $23.92 $2,865 - $4,090	171 Added 0.2%	83,710 $1.64 Million
Q1 2018 May 15, 2018	BUY	$16.16 - $31.31 $93,614 - $181,378	5,793 Added 7.45%	83,539 $1.57 Million
Q4 2017 Feb 09, 2018	BUY	$12.26 - $25.88 $953,165 - $2.01 Million	77,746	77,746 $1.29 Million

Others Institutions Holding VYGR

# of Institutions

130

Shares Held

34.7M

Call Options Held

39.7K

Put Options Held

34.6K

Black Rock Inc. New York, NY

5.31M
Shares

$30.7 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

5.2M
Shares

$30.1 Million
0.5% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.92M
Shares

$22.6 Million
0.99% of portfolio
Vanguard Group Inc Valley Forge, PA

3.19M
Shares

$18.4 Million
0.0% of portfolio
Farallon Capital Management LLC San Francisco, CA

2.29M
Shares

$13.2 Million
0.07% of portfolio

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account